Relationship between cellular glutathione and hyperthermic toxicity in mammary carcinoma in mice.
This investigation evaluates in an in vivo system the possible correlation between the intracellular content of GSH and cysteine and thermal sensitivity and thermotolerance. The studies were performed on C3H mammary carcinomas, located on the hind paw of CBA mice. Intracellular thiols were measured by the HPLC technique and the degree of thermotolerance induction was determined from tumour growth rate studies. It was found that the intracellular GSH levels did not change significantly during thermotolerance induction, and that subtoxic hyperthermia induced a pronounced transient decrease in GSH down to 30 per cent of the control level. When the intracellular GSH level was decreased to the same extent, by pretreatment with D,L-buthionine-S-R-sulphoximine (BSO), thermotolerance was still inducible. Thus, the induction of heat-induced thermal resistance did not seem to be dependent on the intracellular GSH level. When hyperthermia and BSO were combined, the GSH levels were further reduced. Treatment with BSO slightly increased the toxicity of both thermotolerance-inducing and subtoxic hyperthermia. The cysteine concentrations increased several fold after BSO and heat treatments and contributed, under these conditions, to more than 25 per cent of the intracellular free reduced thiols. In general, there was no direct correlation between GSH and cysteine levels. It is concluded that thermotolerance induction does not depend on or cause changes in intracellular GSH levels and that subtoxic heat treatments induce a pronounced transient decrease in GSH concentration.
D000818:Animals; D019328:Buthionine Sulfoximine; D002851:Chromatography, High Pressure Liquid; D003545:Cysteine / Q000032:analysis; D005260:Female; D005978:Glutathione / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006979:Hyperthermia, Induced / Q000009:adverse effects*; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000032:analysis / Q000378:metabolism*; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000494:pharmacology; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D013438:Sulfhydryl Compounds / Q000032:analysis
D013438:Sulfhydryl Compounds; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D005978:Glutathione; D003545:Cysteine